UCB : General Meeting of Shareholders 2024
UCB's General Meeting of Shareholders 2024 For financial year 2023: Gross dividend of € 1.36 per share , payable 30 May 2024 ...
Stay updated with breaking news from Dolca Thomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UCB's General Meeting of Shareholders 2024 For financial year 2023: Gross dividend of € 1.36 per share , payable 30 May 2024 ...
SAN CARLOS, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today
07.08.2023 - Completed enrollment of the GEMINI-1 Phase 3 trial for imsidolimab (IL-36R) in generalized pustular psoriasis (GPP) and anticipate top-line data in Q4 2023Initiating a global Phase 2b trial for rosnilimab, a PD-1 agonist antibody, in rheumatoid ...
Completed enrollment of the GEMINI-1 Phase 3 trial for imsidolimab (IL-36R) in generalized pustular psoriasis (GPP) and anticipate top-line data in Q4...